KYTX ▲ +1.0% - Kyverna Therapeutics, Inc.
$KYTX - Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
21-OCT-2026 07:15 AM ET
Share this post
More filings for $KYTX
KYTX - Kyverna Therapeutics, Inc. - SEC Filing Update (19-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 19, 2026KYTX ▲ +0.6% - Kyverna Therapeutics, Inc.Oct 7, 2026KYTX ▼ -0.4% - Kyverna Therapeutics, Inc.Sep 24, 2026KYTX ▲ +1.6% - Kyverna Therapeutics, Inc.Sep 24, 2026KYTX ▲ +2.9% - Kyverna Therapeutics, Inc.Sep 2, 2026KYTX - Kyverna Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $KYTX filing history →💬 Comments
Loading comments…
Leave a comment